ArticleBMC public health2025
Predictors of willingness of HPV vaccine uptake across Eight States in Nigeria.
Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Determinants of human papillomavirus vaccination uptake in Nigeria: a mixed-methods systematic review.BMC public health · 2026Pooled it
- Early implementation and contextual determinants of the human papillomavirus vaccine rollout and uptake in Nigeria: a mixed-methods study.Frontiers in public health · 2026Article
- Intent to Receive Human Papillomavirus Vaccination among School-going Pre-teens and Adolescent Girls.International journal of MCH and AIDS · 2025Article
- Perceptions of HPV and HPV vaccines among parents and caregivers of girls aged 9-14 years in Nigeria: a qualitative study.Discover public health · 2025Article
- Advances and Challenges in Cervical Cancer: From Molecular Mechanisms and Global Epidemiology to Innovative Therapies and Prevention Strategies.Cancer control : journal of the Moffitt Cancer CenterReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe Nigerian Federal Government planned to launch the Human Papillomavirus (HPV) vaccine on September 25, 2023. We therefore aimed to assess caregiver awareness and willingness regarding HPV vaccine uptake for girls aged 9-14 across eight states (Abia, Adamawa, Bayelsa, Benue, Enugu, FCT, Jigawa, and Taraba), evaluating public readiness for the vaccine rollout.
methodsA cross-sectional telephone survey was conducted in the eight states using a structured questionnaire. Stratified random sampling was employed to ensure representation from each state's three senatorial districts. Adult participants' socio-demographic characteristics-including their relationship to the child, gender, settlement type (rural/urban), and age group-were analyzed. Local Government Area and Senatorial Zone were used solely for geographical representation. Awareness, perceived severity, susceptibility, and willingness for HPV vaccine uptake were calculated based on questionnaire responses. Descriptive statistics, correlation analyses, ordinal and linear regression, and mediation regression were applied to derive results.
resultsOur findings indicated low general HPV awareness but high willingness for vaccine uptake among caregivers. Northern states exhibited higher awareness, perceived severity, susceptibility, and willingness compared to Southern states. Significant differences emerged across states in awareness and willingness, with positive correlations observed among awareness, severity, susceptibility, and willingness. Multiple linear regression revealed that awareness does not directly predict willingness, while mediation regression demonstrated that awareness indirectly influences willingness through severity and susceptibility. The study's implications were analyzed using the Health Belief Model (HBM).
conclusionOur survey found geopolitical disparities in HPV awareness and willingness across Nigeria. Future interventions should prioritize emphasizing the severity and susceptibility of HPV-related diseases, particularly in low-resource settings. Providing accurate information from trusted sources and addressing misconceptions through evidence-based strategies can enhance informed decision-making regarding HPV vaccination.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.